{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:16:03Z","timestamp":1793513763459,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T00:00:00Z","timestamp":1064188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T00:00:00Z","timestamp":1064188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2003,10,1]]},"DOI":"10.1038\/sj.cgt.7700634","type":"journal-article","created":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T08:43:55Z","timestamp":1064220235000},"page":"737-744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":309,"title":["Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients"],"prefix":"10.1038","volume":"10","author":[{"given":"John","family":"Nemunaitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Senzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Litz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cavagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Clairmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sznol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,9,22]]},"reference":[{"key":"BF7700634_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00531349","volume":"63","author":"JR Mose","year":"1959","unstructured":"Mose JR, Mose G . Onkolyseversuche mit apathogenen anaeroben Sporenbildern am Ehrlich Tumor des Maus. Z Krebsforsch. 1959;63:63\u201374.","journal-title":"Z Krebsforsch"},{"key":"BF7700634_CR2","first-page":"212","volume":"24","author":"JR Mose","year":"1964","unstructured":"Mose JR, Mose G . Oncolysis by clostridia. I. Activity of Clostridium butyricum (M-55) and other nonpathogenic clostridia against the Ehrlich carcinoma. Cancer Res. 1964;24:212\u2013216.","journal-title":"Cancer Res"},{"key":"BF7700634_CR3","first-page":"222","volume":"2","author":"EH Thiele","year":"1964","unstructured":"Thiele EH, Arison R, Boxer GE . Oncolysis by clostridia. III. Effects of clostridia and chemotherapeutic agents on rodent tumors. Cancer Res. 1964;2:222\u2013233.","journal-title":"Cancer Res"},{"key":"BF7700634_CR4","first-page":"239","volume":"24","author":"K Engelbart","year":"1954","unstructured":"Engelbart K, Gericke D . Oncolysis by clostridia V. Transplanted tumors of the hamster. Cancer Res. 1954;24:239\u2013243.","journal-title":"Cancer Res"},{"key":"BF7700634_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0014-2964(67)90060-6","volume":"3","author":"RW Carey","year":"1967","unstructured":"Carey RW, Holland JF, Whang HY, et al. Clostridial oncolysis in man. Eur J Cancer. 1967;3:37\u201346.","journal-title":"Eur J Cancer"},{"key":"BF7700634_CR6","first-page":"123","volume":"12","author":"F Heppner","year":"1978","unstructured":"Heppner F, Mose J . The liquefaction (oncolysis) of malignant gliomas by a non-pathogenic clostridium. Acta Neurol. 1978;12:123\u2013125.","journal-title":"Acta Neurol"},{"key":"BF7700634_CR7","unstructured":"Heppner F, Mose J, Ascher PW, Walter G . Oncolysis of malignant gliomas of the brain. The 13th International Congress on Chemotherapy, 1983: vol 226, 38\u201345."},{"key":"BF7700634_CR8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJM195412092512406","volume":"251","author":"CP Giel","year":"1954","unstructured":"Giel CP . Abscess formation in pheochromocytoma. N Engl J Med. 1954;251:980\u2013982.","journal-title":"N Engl J Med"},{"key":"BF7700634_CR9","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3109\/00365529709003000","volume":"32","author":"TA Simmers","year":"1997","unstructured":"Simmers TA, Mijnhout G, Van Meyel JJ . Salmonellosis: an usual complication of hepatocellular carcinoma. Scand J Gastroenterol. 1997;32:1180\u20131182.","journal-title":"Scand J Gastroenterol"},{"key":"BF7700634_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0163-4453(87)91476-9","volume":"15","author":"A Noguerado","year":"1987","unstructured":"Noguerado A, Cabanyes J, Vivancos J, et al. Abscess caused by Salmonella enteritidis within a glioblastoma multiforme. J Infect. 1987;15:61\u201363.","journal-title":"J Infect"},{"key":"BF7700634_CR11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJM196005052621806","volume":"262","author":"PH Black","year":"1960","unstructured":"Black PH, Kunz LJ, Swartz MN . Salmonellosis: a review of some unusual aspects. N Engl J Med. 1960;262:921\u2013926.","journal-title":"N Engl J Med"},{"key":"BF7700634_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/clinids\/8.1.31","volume":"8","author":"RE Rodriguez","year":"1986","unstructured":"Rodriguez RE, Valero V, Watanakunakom C . Salmonella focal intracranial infections: review of the world literature (1884\u20131984) and report of an usual case. Rev Infect Dis. 1986;8:31\u201341.","journal-title":"Rev Infect Dis"},{"key":"BF7700634_CR13","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1136\/bmj.1.4768.1116","volume":"1","author":"FO Grahm","year":"1952","unstructured":"Grahm FO, Coleman PN . Infection of a secondary carcinoma by Salmonella montevideo. BMJ. 1952;1:1116.","journal-title":"BMJ"},{"key":"BF7700634_CR14","first-page":"87","volume":"40","author":"X Luo","year":"1999","unstructured":"Luo X, Ittensohn M, Liu Y, et al. Genetically modified Salmonella typhimurium inhibited growth of primary tumors and metastases. Proc Am Assoc Cancer Res. 1999;40:87.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF7700634_CR15","first-page":"87","volume":"40","author":"K Low","year":"1999","unstructured":"Low K, Ittensohn M, Lin S, et al. VNP20009, a genetically modified Salmonella typhimurium for treatment of solid tumors. Proc Am Assoc Cancer Res. 1999;40:87.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF7700634_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/5205","volume":"17","author":"KB Low","year":"1999","unstructured":"Low KB, Ittensohn M, Le T, et al. Lipid A mutant salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol. 1999;17:37\u201341.","journal-title":"Nat Biotechnol"},{"key":"BF7700634_CR17","first-page":"4537","volume":"57","author":"JM Pawelek","year":"1997","unstructured":"Pawelek JM, Low KB, Bermudes D . Tumor-targeted salmonella as a novel anticancer vector. Cancer Res. 1997;57:4537\u20134544.","journal-title":"Cancer Res"},{"key":"BF7700634_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1046\/j.1365-2958.1998.00952.x","volume":"29","author":"SA Khan","year":"1998","unstructured":"Khan SA, Everest P, Servos S . A lethal role for lipid A in salmonella infection. Mol Microbiol. 1998;29:571\u2013579.","journal-title":"Mol Microbiol"},{"key":"BF7700634_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/109158101750408037","volume":"20","author":"KC Lee","year":"2001","unstructured":"Lee KC, Zheng LM, Margitich D, Almassian B, King I . Evaluation of the acute and subchronic toxic effects in mice, rats, and monkeys of the genetically engineered and Escherichia coli cytosine deaminase gene-incorporated Salmonella strain. TAPET-CD, being developed as an anti-tumor agent. Int J Toxicol. 2001;20:207\u2013217.","journal-title":"Int J Toxicol"},{"key":"BF7700634_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3727\/096504001108747602","volume":"12","author":"LM Zheng","year":"2000","unstructured":"Zheng LM, Luo X, Feng M, et al. Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector. Oncol Res. 2000;12:127\u2013135.","journal-title":"Oncol Res"},{"key":"BF7700634_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3727\/096504001108747512","volume":"12","author":"X Luo","year":"2002","unstructured":"Luo X, Li Z, Lin S, et al. Anti-tumor effect of VNP20009, an attenuated Salmonella, in murine tumor models. Oncol Res. 2002;12:501\u2013508.","journal-title":"Oncol Res"},{"key":"BF7700634_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso JF, Gill VJ, Hwu P, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol. 2002;20:142\u2013152.","journal-title":"J Clin Oncol"},{"key":"BF7700634_CR23","doi-asserted-by":"publisher","first-page":"321S","DOI":"10.1378\/chest.112.6_Supplement.321S","volume":"112","author":"CA Dinarello","year":"1997","unstructured":"Dinarello CA . Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 1997;112:321S\u2013329S.","journal-title":"Chest"},{"key":"BF7700634_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1089\/104303402320139005","volume":"13","author":"I King","year":"2002","unstructured":"King I, Bermudes D, Lin S, et al. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. Hum Gene Ther. 2002;13:1225\u20131233.","journal-title":"Hum Gene Ther"},{"key":"BF7700634_CR25","first-page":"235","volume":"2","author":"MP Deonarain","year":"1995","unstructured":"Deonarain MP, Spooner RA, Epenetos AA . Genetic delivery of enzymes for cancer therapy. Gene Therapy. 1995;2:235\u2013244.","journal-title":"Gene Therapy"},{"key":"BF7700634_CR26","unstructured":"Haskell CM, Fluorouracil. In: In Cancer Treatment. WB Sounds Company. 1995: 116\u2013119."},{"key":"BF7700634_CR27","first-page":"380","volume":"43","author":"EA Austin","year":"1993","unstructured":"Austin EA, Huber BE . A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing and expression of Escherichia coli cytosine deaminase. Mol Pharmacol. 1993;43:380\u2013387.","journal-title":"Mol Pharmacol"},{"key":"BF7700634_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.gt.3301659","volume":"9","author":"SC Liu","year":"2002","unstructured":"Liu SC, Minton NP, Giaccia AJ, Brown JM . Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia\/necrosis. Gene Therapy. 2002;9:291\u2013296.","journal-title":"Gene Therapy"},{"key":"BF7700634_CR29","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1128\/iai.59.12.4310-4317.1991","volume":"59","author":"MS Donnenburg","year":"1991","unstructured":"Donnenburg MS, Kaper JB . Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immunity. 1991;59:4310\u20134317.","journal-title":"Infect Immunity"},{"key":"BF7700634_CR30","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/S0959-8049(00)00336-1","volume":"36","author":"J Platt","year":"2000","unstructured":"Platt J, Sodi S, Kelly M, et al. Antitumor effects of genetically engineered Salmonella in combination with radiation. Eur J Cancer. 2000;36:2397\u20132402.","journal-title":"Eur J Cancer"},{"key":"BF7700634_CR31","first-page":"53","volume":"2","author":"MS Khil","year":"1996","unstructured":"Khil MS, Kim JH, Mullen CA, et al. Radiosensitization of 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene. Clin Cancer Res. 1996;2:53\u201357.","journal-title":"Clin Cancer Res"},{"key":"BF7700634_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0360-3016(98)00125-4","volume":"41","author":"M Gabel","year":"1998","unstructured":"Gabel M, Kim JH, Kolozsvary A, et al. Selective in vivo radiosensitization by 5-fluorouracil of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase gene. Int J Radiat Oncol Biol Phys. 1998;41:883\u2013887.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF7700634_CR33","first-page":"2588","volume":"58","author":"TS Lawrence","year":"1998","unstructured":"Lawrence TS, Rehemtulla A, Ng EY . Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-fluorocytosine. Cancer Res. 1998;58:2588\u20132593.","journal-title":"Cancer Res"},{"key":"BF7700634_CR34","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.4049\/jimmunol.154.10.5302","volume":"154","author":"M Consalvo","year":"1995","unstructured":"Consalvo M, Mullen CA, Modesti A, et al. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves and efficient memory. J Immunol. 1995;154:5302\u20135312.","journal-title":"J Immunol"},{"key":"BF7700634_CR35","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/jnci\/91.23.2014","volume":"91","author":"V Pierrefite-Carle","year":"1999","unstructured":"Pierrefite-Carle V, Baque P, Gavelli A, et al. Cytosine deaminase\/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J Natl Cancer Inst. 1999;91:2014\u20132019.","journal-title":"J Natl Cancer Inst"},{"key":"BF7700634_CR36","first-page":"334","volume":"4","author":"T Hermiston","year":"2002","unstructured":"Hermiston T . Fighting fire with fire: attacking the complexity of human tumors with armed therapeutic viruses. Curr Opin Mol Ther. 2002;4:334\u2013342.","journal-title":"Curr Opin Mol Ther"},{"key":"BF7700634_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1040-8428(01)00103-2","volume":"38","author":"E Galanis","year":"2001","unstructured":"Galanis E, Vile R, Russell SJ . Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors. Crit Rev Oncol Hematol. 2001;38:177\u2013192.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF7700634_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H","volume":"187","author":"O Greco","year":"2001","unstructured":"Greco O, Dachs GU . Gene directed enzyme\/prodrug therapy of cancer: historical appraisal and future prospectives. J Cell Physiol. 2001;187:22\u201336.","journal-title":"J Cell Physiol"},{"key":"BF7700634_CR39","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1089\/hum.1997.8.8-985","volume":"8","author":"RG Crystal","year":"1997","unstructured":"Crystal RG, Hirschowitz E, Lieberman M, et al. Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine. Hum Gene Ther. 1997;8:985\u20131001.","journal-title":"Hum Gene Ther"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7700634","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700634.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700634.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T20:12:19Z","timestamp":1704917539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7700634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,22]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10,1]]}},"alternative-id":["BF7700634"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7700634","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,22]]},"assertion":[{"value":"19 February 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2003","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}